Przegląd Dermatologiczny

Pełna treść

1/2026 vol. 113
Artykuł przeglądowy

Role of Vitamin D in Human Papillomavirus Infection: a Review Article

Sarah Adelia 1, 2, 3
,
Regitta Indira Agusni 1, 3, 4
,
Septiana Widyantari 1, 2
,
Astindari Astindari 1, 2
,
Afif Nurul Hidayati 1, 3
,
Dwi Murtiastutik 1, 2

  1. Department of Dermatology Venereology and Aesthetics, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

  2. Dr. Soetomo General Academic Hospital, Surabaya, Indonesia

  3. Universitas Airlangga Hospital, Surabaya, Indonesia

  4. Leprosy Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia

DOI: https://doi.org/10.5114/dr.2026.162024
Data publikacji online: 2026/06/05
Plik artykułu
Role of Vitamin D.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Kaur J., Khare S., Sizar O.: Vitamin D deficiency. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Aug 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532266/
  2. Dominguez L.J., Farruggia M., Veronese N., Barbagallo M.: Vitamin D sources, metabolism, and deficiency: available compounds and guidelines for its treatment. Metabolites 2021, 11, 255.
  3. Sassi F., Tamone C., D’Amelio P.: Vitamin D: nutrient, hormone, and immunomodulator. Nutrients 2018, 10, 1656.
  4. Lee C.: Controversial effects of vitamin D and related genes on viral infections, pathogenesis, and treatment outcomes. Nutrients 2020, 12, 962.
  5. Kang S., Amagai M., Bruckner A.L., Enk A.H., Margolis D.J., McMIchael A.J., et al.: Fitzpatrick’s Dermatology. 9th ed. New York: McGraw Hill; 2019.
  6. de Sanjosé S., Brotons M., Pavón M.A.: The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol 2018, 47, 2-13.
  7. Maghiar L., Sandor M., Sachelarie L., Bodog R., Huniadi A.: Skin lesions caused by HPV – a comprehensive review. Biomedicines 2024, 12, 2098.
  8. Cao Y., Zhou X., Yang H.: Association of vitamin D with risk of warts: a retrospective and Mendelian randomization study. Skin Res Technol 2024, 30, e13911.
  9. Mostafa W.Z., Hegazy R.A.: Vitamin D and the skin: focus on a complex relationship: a review. J Adv Res 2015, 6, 793-804.
  10. Bocheva G., Slominski R.M., Slominski A.T.: The impact of vitamin D on skin aging. Int J Mol Sci 2021, 22, 9097.
  11. Ramasamy I.: Vitamin D metabolism and guidelines for vitamin D supplementation. Clin Biochem Rev 2020, 41, 103-126.
  12. Ismailova A., White J.H.: Vitamin D, infections and immunity. Rev Endocr Metab Disord 2021, 23, 265-277.
  13. Kechichian E., Ezzedine K.: Vitamin D and the skin: an update for dermatologists. Am J Clin Dermatol 2017, 19, 223-235.
  14. Nimitphong H., Holick M.F.: Vitamin D status and sun exposure in Southeast Asia. Dermatoendocrinology 2013, 5, 34-37.
  15. Rebelos E., Tentolouris N., Jude E.: The role of vitamin D in health and disease: a narrative review on the mechanisms linking vitamin D with disease and the effects of supplementation. Drugs 2023, 83, 665-685.
  16. Bikle D.D.: Vitamin D and the skin: physiology and pathophysiology. Rev Endocr Metab Disord 2011, 13, 3-19.
  17. Hewison M.: An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 2012, 76, 315-325.
  18. Wei R., Christakos S.: Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D. Nutrients 2015, 7, 8251-8260.
  19. Luria L., Cardoza-Favarato G.: Human papillomavirus. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2025 Aug 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448132/
  20. Holmes K.K., Sparling P.F., Stamm W.E., Piot P., Wasserheit J.N., Corey L., et al.: Sexually transmitted diseases. 4th ed. New York: McGraw Hill Professional; 2007.
  21. Harden M.E., Munger K.: Human papillomavirus molecular biology. Mutat Res Rev Mutat Res 2017, 772, 3-12.
  22. Soheili M., Keyvani H., Soheili M., Nasseri S.: Human papilloma virus: a review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers. Med J Islam Repub Iran 2021, 35, 65.
  23. Burd E.M.: Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003, 16, 1-17.
  24. Syrjänen S.: Oral manifestations of human papillomavirus infections. Eur J Oral Sci 2018, 126 (S1), 49-66.
  25. Forcier M., Musacchio N.: An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention. Dermatol Ther 2010, 23, 458-476.
  26. Wakabayashi R., Nakahama Y., Nguyen V., Espinoza J.L:. The host–microbe interplay in human papillomavirus-induced carcinogenesis. Microorganisms 2019, 7, 199.
  27. Skubic L., Breznik V., Poljak M.: Different skin wart types, different human papillomavirus types? A narrative review. Acta Dermatovenerol Alp Pannonica Adriat 2023, 32, 165-171.
  28. Cristaudo A., Giuliani M.: Sexually transmitted infections: advances in understanding and management. Cham: Springer Nature; 2020.
  29. Rm P., Manuvidhya H., Priyadarshini A., Joseph LD., Swaminathan A.: Epidermodysplasia verruciformis: a case series. Cureus 2025, 17, e78058.
  30. Benedict J.J., Derkay C.S.: Recurrent respiratory papillomatosis: a 2020 perspective. Laryngoscope Investig Otolaryngol 2021, 6, 340-345.
  31. Accardi R., Gheit T.: Cutaneous HPV and skin cancer. Presse Med 2014, 43, e435-e443.
  32. Xu C., Liu J.: Influence of vitamin D supplementation and the vaginal microenvironment on human papillomavirus infection. Afr J Reprod Health 2024, 28, 91-100.
  33. Schulte-Uebbing C., Schlett S., Craiut I., Antal L., Olah H.: Chronical cervical infections and dysplasia (CIN I, CIN II): vaginal vitamin D (high dose) treatment: a new effective method? Dermatoendocrinology 2014, 6, e27791.
  34. Vahedpoor Z., Jamilian M., Bahmani F., Aghadavod E., Karamali F., Tajabadi-Ebrahimi M., et al.: Effects of long-term vitamin D supplementation on regression and metabolic status of cervical intraepithelial neoplasia: a randomized, double-blind, placebo-controlled trial. Horm Cancer 2017, 8, 58-67.
  35. Özgü E., Yılmaz N., Başer E., Güngör T., Erkaya S., Yakut H.I.: Could 25-OH vitamin D deficiency be a reason for HPV infection persistence in cervical premalignant lesions? J Exp Ther Oncol 2016, 11, 177-180.
  36. Shim J., Pérez A., Symanski E., Nyitray A.G.: Association between serum 25-hydroxyvitamin D level and human papillomavirus cervicovaginal infection in women in the United States. J Infect Dis 2016, 213, 1886-1892.
  37. Shalaby M.E., Hasan M.S., Elshorbagy M.S., Abo Raya A.R., Elsaie M.L.: Diagnostic and therapeutic implications of vitamin D deficiency in patients with warts: a case-controlled study. J Cosmet Dermatol 2022, 21, 1135-1142.
  38. El Mongy N.N., Hilal R.F., Badr A.M., Alraawi S.A.: Serum vitamin D level in patients with viral warts. J Egypt Womens Dermatol Soc 2018, 15, 133-138.
  39. Gupta A., Villa A., Feldman S., Citow B., Sroussi H.: Site- and sex-specific differences in the effect of vitamin D on human papillomavirus infections: analyses of NHANES 2009–2014. Sex Transm Infect 2021, 97, 75-76.
  40. Tamer F., Yuksel M.E., Karabag Y.: Pre-treatment vitamin B12, folate, ferritin, and vitamin D serum levels in patients with warts: a retrospective study. Croat Med J 2020, 61, 28-32.
  41. El-Zein M., Khosrow-Khavar F., Burchell A.N., Tellier P.P., Eintracht S., McNamara E., et al.: Association of serum 25-hydroxyvitamin D with prevalence, incidence, and clearance of vaginal HPV infection in young women. J Infect Dis 2021, 224, 492-502.
  42. García-Carrasco M., Mendoza-Pinto C., Munguía-Realpozo P., Rodríguez-Gallegos A., Vallejo-Ruiz V., Muñoz-Guarneros M., et al.: Lack of association between serum 25-hydroxyvitamin D levels and cervical human papillomavirus infection in systemic lupus erythematosus. Lupus 2015, 24, 606-612.
  43. Demir A., Güder S.: The effects of vitamin B12, vitamin D, ferritin level, neutrophil/monocyte ratio and some blood parameters on genital warts presence, the number of lesions, and recurrence rates. Andrologia 2021, 53, e14006.
  44. Koc S., Kurt S., Ilgen O., Timur H.T., Uslu T.: The effect of vitamin D on the regression of human papilloma virus infection and metabolic parameters: a retrospective study. Eur J Gynaecol Oncol 2021, 42, 340-345.
  45. Aryal E., Bhari J., Shrestha P.R.: Immunotherapy with intralesional vitamin D injection in recalcitrant wart at a tertiary care center: a descriptive cross-sectional study. J Nepal Med Assoc 2024, 62, 378-381.
  46. Ali M., Malik K., Bashir B., Saeed A., Shahzad A., Malik L.M.: Efficacy of intralesional vitamin D3 in plantar warts. J Pak Assoc Dermatol 2023, 33, 1495-1499.
  47. Al-Sabak H., Al-Hattab M., Al-Rammahi M., Al-Dhalimi M.: The efficacy of intralesional vitamin D3 injection in the treatment of cutaneous warts: a clinical therapeutic trial study. Skin Res Technol 2023, 29, e13442.
  48. Noureen U., Shah R.R., Waqas N., Sharif S., Shah A., Rao B.K.: Efficacy of intralesional vitamin D3 for treatment of verruca vulgaris: a randomized control study. J Clin Aesthet Dermatol 2023, 16, 47-50.
  49. Sharma G., Sharma S.: Efficacy of intralesional immunotherapy with vitamin D3 injection in cutaneous warts: a clinical observational study. Clin Dermatol Rev 2023, 7, 272-276.
  50. Latif I., Sultan J., Aslam A., Hassan I., Devi R.: Role of intralesional vitamin D3 in the treatment of cutaneous warts. J Cutan Aesthet Surg 2021, 14, 404-408.
  51. Sorour N.E., Elesawy F.M., Abdou A.G., Abdelazeem S.E., Akl E.M.: Intralesional injection of vitamin D in verruca vulgaris increases cathelicidin (LL37) expression: therapeutic and immunohistochemical study. J Dermatolog Treat 2022, 33, 291-296.
  52. Abdel-Azim E., Abdel-Aziz R.A., Ragaie M., Mohamed E.: Clinical and dermoscopic evaluation of intralesional vitamin D3 in treatment of cutaneous warts: a placebo-controlled study. J Egypt Womens Dermatol Soc 2020, 17, 6.
  53. Alfetory T., Duweb G.: Efficacy, safety and tolerability of intralesional vitamin D in the treatment of Libyan cutaneous wart patients. J Adv Med Med Res 2023, 35, 65-74.
  54. Mohta A., Jain S.K.: Recalcitrant periungual warts in a paediatric patient treated with intralesional vitamin D3. Indian J Med Res 2020, 152 (Suppl 1), S44.
  55. Merry S., Thacher T., Brennan D., O’Dowd E.: Intralesional injections of vitamin D are ineffective for the treatment of cutaneous warts. Am Fam Physician 2024, 20, 6107.
  56. Shaafie H.I., Koti V.R., Saxena K., Shukla P.: Intralesional immunotherapy of cutaneous warts using tuberculin purified protein derivative and vitamin D3: a randomized comparative study. J Cutan Aesthet Surg 2025, 18, 86-91.
  57. Chaudhary M., Brar A., Agarwal P., Chavda V., Jagati A., Rathod S.P.: A study of comparison and evaluation of various intralesional therapies in cutaneous warts. Indian Dermatol Online J 2023, 14, 487-492.
  58. Fathy G., Sharara M.A., Khafagy A.H.: Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: a comparative case-control study. Dermatol Ther 2019, 32, e12997.
  59. Lahoria U., Singh S., Bhardwaj A., Budania A., Chhajed N., Rajagopal S.V., et al.: A prospective randomized controlled study of Mycobacterium indicus pranii vaccine, measles mumps rubella vaccine and vitamin D3 in extragenital cutaneous warts. J Cosmet Dermatol 2023, 22, 1400-1409.
  60. Nasr M., Abdelaty S., Elkholy B.M.: A comparative clinico-dermoscopic study of intralesional injection of combined digoxin and furosemide, Candida antigen, and vitamin D3 for multiple warts. J Cosmet Dermatol 2023, 22, 1344-1353.
  61. Abdelaal M.A., Abdelaziz H.M., Ahmed K.A., Elsaie M.L.: Comparative study of intralesional vitamin D3 injection and Candida albicans antigen in treating plantar warts. J Drugs Dermatol 2021, 20, 546-549.
  62. Abd El-Magid W.M., Nada E.E.A., Mossa R.A.: Intralesional injection of vitamin D3 versus zinc sulfate 2% in treatment of plantar warts: a comparative study. J Dermatolog Treat 2021, 32, 355-360.
  63. El Sayed M.H., Sayed F.S., Afify A.A.: Intralesional zinc sulfate 2% vs intralesional vitamin D in plantar warts: a clinicodermoscopic study. Dermatol Ther 2020, 33, e13308.
  64. Ghaly N.E., El-Ashmawy A.A., Zeid M.A., Shaker E.S.E.: Efficacy and safety of intralesional injection of vitamin D3 versus tuberculin PPD in the treatment of plantar warts: a comparative controlled study. J Cosmet Dermatol 2021, 20, 1231-1240.
  65. Nofal A., Albalat W., Ismail A., Khattab F.M.: Immunotherapeutic modalities for the treatment of recalcitrant plantar warts: a comparative study. J Dermatolog Treat 2022, 33, 922-927.
  66. Mohta A., Kushwaha R.K., Agrawal A., Sharma M.K., Gautam U., Jain S.K.: Evaluation of the efficacy of intralesional measles, mumps, and rubella vaccine with intralesional vitamin D3 as immunotherapies in the treatment of recalcitrant cutaneous warts in adult: a randomized placebo-controlled study. Indian Dermatol Online J 2021, 12, 879-887.
  67. Abdel Razik L.H., Obaid Z.M., Fouda I.: Intralesional Candida antigen versus intralesional vitamin D3 in the treatment of recalcitrant multiple common warts. J Cosmet Dermatol 2021, 20, 3341-3346.
  68. Jha N.: Complete clearance of condyloma acuminata using injection vitamin D3. Australas J Dermatol 2021, 62, e417-e418.
  69. Tawfik Y., Hosny A., El-Gazzar A., Bakr R.: Efficacy and safety of treating anogenital warts with intralesional vitamin D3 injection: a report on 20 Egyptian patients. Al-Azhar Assiut Med J 2020, 18, 140.
  70. Almuhyi R.A., Alhamdi K.I., Alhamdi D.K.: Topical vitamin D3 derivative (calcipotriol) versus intralesional vitamin D3 in the treatment of cutaneous warts: a clinical therapeutic comparative trial. Dermatol Res Pract 2024, 2024, 5236290.
  71. Elmas Ö.F., Atasoy M., Akdeniz N., Özyurt K.: A recalcitrant case of facial verruca plana successfully treated with topical calcipotriol alone. Dermatol Ther 2020, 33, e13664.
  72. Brust M., Linxweiler M., Schnatmann J., Kühn J.P., Knebel M., Braun F.L., et al.: Effects of vitamin D on tumor cell proliferation and migration, tumor initiation, and immune infiltration in a head and neck squamous cell carcinoma model. Biomed Pharmacother 2024, 180, 117497.
  73. El-Taweel A.E.A., Salem R.M., Allam A.H.: Cigarette smoking reduces the efficacy of intralesional vitamin D in the treatment of warts. Dermatol Ther 2019, 32, e1281
Copyright: © 2026 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Indeks osobowy
Udostępnij
without publication fees
without publication fees
Dostępne w
Zintergrowane z
plagiat pl
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications